Semaglutide: GLP-1 Receptor Agonist Research, Mechanism & Clinical Data
For informational and research purposes only. This article does not constitute medical advice. What Is Semaglutide? Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk.
